GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Hangzhou Tigermed Consulting Co Ltd (HKSE:03347) » Definitions » Cash from Discontinued Operating Activities

Hangzhou Tigermed Consulting Co (HKSE:03347) Cash from Discontinued Operating Activities : HK$0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Hangzhou Tigermed Consulting Co Cash from Discontinued Operating Activities?

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

Hangzhou Tigermed Consulting Co's Cash from Discontinued Operating Activities for the three months ended in Sep. 2024 was HK$0 Mil. It means Hangzhou Tigermed Consulting Co received HK$0 Mil from discontinued investing activities. Hangzhou Tigermed Consulting Co's Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Sep. 2024 was HK$0 Mil.

Hangzhou Tigermed Consulting Co Cash from Discontinued Operating Activities Historical Data

The historical data trend for Hangzhou Tigermed Consulting Co's Cash from Discontinued Operating Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Tigermed Consulting Co Cash from Discontinued Operating Activities Chart

Hangzhou Tigermed Consulting Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash from Discontinued Operating Activities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Hangzhou Tigermed Consulting Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash from Discontinued Operating Activities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Hangzhou Tigermed Consulting Co Cash from Discontinued Operating Activities Calculation

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hangzhou Tigermed Consulting Co Cash from Discontinued Operating Activities Related Terms

Thank you for viewing the detailed overview of Hangzhou Tigermed Consulting Co's Cash from Discontinued Operating Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

Hangzhou Tigermed Consulting Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Hangzhou Tigermed Consulting Co Ltd (HKSE:03347) » Definitions » Cash from Discontinued Operating Activities
Comparable Companies
SHSE:603882 SZSE:300676 SHSE:603127 SZSE:300244 SHSE:603108 SZSE:300406 SZSE:300463 SZSE:300685 SZSE:300396 SZSE:300639 TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN
Traded in Other Exchanges
HNGZY:USA 300347:China
Address
Block 8, No. 19 Jugong Road, Room 2001-2010, 20th Floor, Xixing Sub-District, Binjiang District, Hangzhou, CHN, 310053
Website
https://www.tigermed.net
Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's segment includes Clinical trial solutions and Clinical-related and laboratory services. It generates maximum revenue from the Clinical trial solutions segment. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.
Executives
Yi Fang Da Ji Jin Guan Li You Xian Gong Si 2102 Investment manager
Sands Capital Management, Llc 2101 Beneficial owner
Sands Capital Management, Lp 2201 Interest of corporation controlled by you
Sands Family Trust, Llc 2201 Interest of corporation controlled by you
Sands Frank Melville Jr. 2201 Interest of corporation controlled by you
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
F-j Sands Family I, Llc 2201 Interest of corporation controlled by you
2017 Eagle Holdings Llc 2201 Interest of corporation controlled by you
Citigroup Inc. 2201 Interest of corporation controlled by you
Ubs Group Ag 2201 Interest of corporation controlled by you
Blackrock, Inc. 2201 Interest of corporation controlled by you
Brown Brothers Harriman & Co. 2502 Approved lending agent
Ninety One Plc/ Ninety One Ltd 2102 Investment manager
Ninety One Uk Limited 2102 Investment manager
Baillie Gifford & Co 2102 Investment manager

Hangzhou Tigermed Consulting Co Headlines

No Headlines